Eosinophils develop in distinct stages and are recruited to peripheral sites by alternatively activated macrophages

Eosinophils are associated with allergic diseases and helminth infections. Development of these cells and recruitment to peripheral tissues are only partially understood. Distinct stages of eosinophil development in fetal liver, bone marrow, and blood could be identified using IL‐4 reporter mice and mAb against FIRE, Siglec‐F, and CCR3. Immature eosinophils were present in the fetal liver and could reconstitute the eosinophil compartment in irradiated recipient mice. In adult mice, eosinophil maturation proceeded from CCR3− to CCR3+ cells in the bone marrow and was accompanied with changes in the transcriptional profile. Eosinophils appeared as activated cells in lung, thymus, lymph nodes, and Peyer’s patches but remained in a resting state in bone marrow, blood, and spleen. Mixed bone marrow chimeras revealed that recruitment to lung and peritoneum was dependent on Stat6 expression in noneosinophils. Alternatively activated macrophages contributed substantially to tissue recruitment of eosinophils, providing a novel basis for development of therapeutic approaches to lower tissue eosinophilia.

[1]  K. Takatsu,et al.  Involvement of complement and fibronectin in eosinophil‐mediated damage to Nippostrongylus brasiliensis larvae , 2001, Parasite immunology.

[2]  J. Drazen,et al.  Characterization of a receptor for C5a anaphylatoxin on human eosinophils. , 1989, The Journal of biological chemistry.

[3]  R. Ashworth,et al.  Activity of rat peritoneal eosinophils following induction by different methods. , 1987, International archives of allergy and applied immunology.

[4]  F. Lund,et al.  Systemic Dissemination and Persistence of Th2 and Type 2 Cells in Response to Infection with a Strictly Enteric Nematode Parasite1 , 2005, The Journal of Immunology.

[5]  D. Friend,et al.  The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  M. Horton,et al.  Expression of IL-5 in thymocytes/T cells leads to the development of a massive eosinophilia, extramedullary eosinophilopoiesis, and unique histopathologies. , 1997, Journal of immunology.

[7]  R. Locksley,et al.  Analysis of type 2 immunity in vivo with a bicistronic IL-4 reporter. , 2001, Immunity.

[8]  Hua Huang,et al.  IL-4 Induces Differentiation and Expansion of Th2 Cytokine-Producing Eosinophils 1 , 2004, The Journal of Immunology.

[9]  K. Kim,et al.  Eosinophilic granulopoiesis in human fetal liver , 1993, The Anatomical record.

[10]  G. Zimmerman,et al.  Platelet-activating Factor , 1991 .

[11]  S. Fleury,et al.  Activation of the Prostaglandin D2 Receptor DP2/CRTH2 Increases Allergic Inflammation in Mouse 1 , 2005, The Journal of Immunology.

[12]  D. Jones The eosinophil. , 1993, Journal of comparative pathology.

[13]  S. Nishikawa,et al.  The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene , 1990, Nature.

[14]  M. Cooper,et al.  A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Y. Aizawa,et al.  Novel technique for the direct flow cytofluorometric analysis of human basophils in unseparated blood and bone marrow, and the characterization of phenotype and peroxidase of human basophils. , 1999, Cytometry.

[16]  T. Graf,et al.  Making Eosinophils Through Subtle Shifts in Transcription Factor Expression , 2002, The Journal of experimental medicine.

[17]  M. Strath,et al.  Eosinophilia in transgenic mice expressing interleukin 5 , 1990, The Journal of experimental medicine.

[18]  H. Kita,et al.  Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils. , 1996, Journal of immunology.

[19]  M. Litt STUDIES IN EXPERIMENTAL EOSINOPHILIA , 1961, The Journal of cell biology.

[20]  P. Loke,et al.  A Brugia malayi Homolog of Macrophage Migration Inhibitory Factor Reveals an Important Link Between Macrophages and Eosinophil Recruitment During Nematode Infection1 , 2001, The Journal of Immunology.

[21]  S. Rankin,et al.  Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. , 1998, Blood.

[22]  P. Foster,et al.  Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. , 1997, The Journal of clinical investigation.

[23]  J. Miyazaki,et al.  Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5R alpha-deficient mice. , 1996, Immunity.

[24]  L. Lanier,et al.  Activation of Natural Killer Cells and Dendritic Cells upon Recognition of a Novel CD99-like Ligand by Paired Immunoglobulin-like Type 2 Receptor , 2004, The Journal of experimental medicine.

[25]  D. Voehringer,et al.  Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. , 2004, Immunity.

[26]  D. Voehringer,et al.  Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system , 2006, The Journal of experimental medicine.

[27]  S. Gordon Alternative activation of macrophages , 2003, Nature Reviews Immunology.

[28]  A. Gessner,et al.  Mast Cells, Basophils, and Eosinophils Acquire Constitutive IL-4 and IL-13 Transcripts during Lineage Differentiation That Are Sufficient for Rapid Cytokine Production1 , 2005, The Journal of Immunology.

[29]  A. Wardlaw,et al.  Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. , 1986, The Journal of clinical investigation.

[30]  B. Aronow,et al.  Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. , 2006, The Journal of clinical investigation.

[31]  N. Sarvetnick,et al.  STAT4/6-dependent differential regulation of chemokine receptors. , 2006, Clinical immunology.

[32]  D. Vinatier,et al.  Decreased expression of eosinophil peroxidase and major basic protein messenger RNAs during eosinophil maturation. , 1992, Blood.

[33]  T. Fujita,et al.  Carbohydrate-binding specificities of mouse ficolin A, a splicing variant of ficolin A and ficolin B and their complex formation with MASP-2 and sMAP , 2005, Immunogenetics.

[34]  G. Mayrhofer,et al.  Trapping and Immobilization ofNippostrongylus brasiliensis Larvae at the Site of Inoculation in Primary Infections of Interleukin-5 Transgenic Mice , 1999, Infection and Immunity.

[35]  R. Locksley,et al.  Helper T cells regulate type-2 innate immunity in vivo , 2002, Nature.

[36]  K. Akashi,et al.  Identification of eosinophil lineage–committed progenitors in the murine bone marrow , 2005, The Journal of experimental medicine.

[37]  P. Crocker,et al.  The murine inhibitory receptor mSiglec‐E is expressed broadly on cells of the innate immune system whereas mSiglec‐F is restricted to eosinophils , 2004, European journal of immunology.

[38]  M. Rothenberg,et al.  Peyer's patch eosinophils: identification, characterization, and regulation by mucosal allergen exposure, interleukin-5, and eotaxin. , 2000, Blood.

[39]  S. Orkin,et al.  Targeted Deletion of a High-Affinity GATA-binding Site in the GATA-1 Promoter Leads to Selective Loss of the Eosinophil Lineage In Vivo , 2002, The Journal of experimental medicine.

[40]  L. Hassman,et al.  Pulmonary Chemokine Expression Is Coordinately Regulated by STAT1, STAT6, and IFN-γ , 2004, The Journal of Immunology.

[41]  P. Hodgkin,et al.  IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. , 1996, Immunity.

[42]  A. Luster,et al.  Molecular and Biological Characterization of the Murine Leukotriene B4 Receptor Expressed on Eosinophils , 1998, The Journal of experimental medicine.

[43]  Qingxian Lu,et al.  Macrophage regulation by Tyro 3 family receptors. , 2003, Current opinion in immunology.

[44]  M. Baggiolini,et al.  Eotaxin-2, a Novel CC Chemokine that Is Selective for the Chemokine Receptor CCR3, and Acts Like Eotaxin on Human Eosinophil and Basophil Leukocytes , 1997, The Journal of experimental medicine.

[45]  P. Foster,et al.  Eosinophils Promote Allergic Disease of the Lung by Regulating CD4+ Th2 Lymphocyte Function1 , 2001, The Journal of Immunology.

[46]  P. Weller,et al.  Lymph node trafficking and antigen presentation by endobronchial eosinophils. , 2000, The Journal of clinical investigation.

[47]  P. Giacomin,et al.  Loss of Complement Activation and Leukocyte Adherence as Nippostrongylus brasiliensis Develops within the Murine Host , 2005, Infection and Immunity.